Internal Medicine, Hematology & Oncology · The Woodlands, TX
NPI
1306856513
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
3115 College Park Dr, Suite 108
The Woodlands, TX, 77384
Phone (936) 439-5213
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.2M
167,558 services
Medicare patients, 2024
266
Average age 77
Drug cost, 2024
$2.9M
1,166 prescriptions
Company payments, 2025
$15.3
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Elham Abbasi-Hafshejani was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 70,890 times for 42 patients. In total Elham Abbasi-Hafshejani billed 167,558 services in 88 codes, and Medicare paid $2.2M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-11-23.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 70,890 | 42 | $0.27 | $19K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 21,600 | 11 | $43.34 | $936K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 7,788 | 44 | $0.07 | $570 |
| J1453 Injection, fosaprepitant, 1 mg | Office | 7,350 | 12 | $0.11 | $808 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 4,952 | 40 | $0.09 | $430 |
| 96367 Intravenous Infusion, Hydration | Office | 1,863 | 89 | $22.37 | $42K |
| 85025 Blood Count | Office | 1,044 | 187 | $7.31 | $7,629 |
| 99214 Office E&M - Established | Office | 932 | 235 | $95.14 | $89K |
| J0897 Injection, denosumab, 1 mg | Office | 900 | 15 | $19.51 | $18K |
| J7030 Infusion, normal saline solution , 1000 cc | Office | 852 | 107 | $2.05 | $1,744 |
| J3475 Injection, magnesium sulfate, per 500 mg | Office | 826 | 25 | $0.45 | $371 |
| 96361 Intravenous Infusion, Hydration | Office | 814 | 105 | $9.67 | $7,873 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 761 | 89 | $0.63 | $478 |
| 99213 Office E&M - Established | Office | 630 | 100 | $70.84 | $45K |
| 96365 Intravenous Infusion, Hydration | Office | 465 | 96 | $47.53 | $22K |
By year: 2022 $2.0M for 182,253 services; 2023 $2.2M for 146,023 services; 2024 $2.2M for 167,558 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,044 | 187 | $7.31 | $7,629 |
Medicare prescription drug claims, 2024
In 2024, the drug Elham Abbasi-Hafshejani prescribed most often to Medicare patients was Anastrozole, with 155 prescriptions and refills. In total Elham Abbasi-Hafshejani wrote 1,166 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 155 | 331 | 35 | $2,108 |
| Potassium Chloride Generic | 130 | 207 | 46 | $2,547 |
| Levothyroxine Sodium Generic | 76 | 106 | 14 | $447 |
| Eliquis Apixaban | 50 | 58 | Under 11 | $33K |
| Warfarin Sodium Generic | 48 | 102 | Under 11 | $301 |
| Lenalidomide Generic | 41 | 41 | Under 11 | $446K |
| Hydroxyurea Generic | 39 | 85 | Under 11 | $1,857 |
| Ondansetron Hcl Generic | 34 | 34 | 25 | $343 |
| Prednisone Generic | 33 | 40 | 18 | $163 |
| Gabapentin Generic | 32 | 52 | 15 | $414 |
| Letrozole Generic | 32 | 66 | Under 11 | $643 |
| Valacyclovir Valacyclovir Hcl | 29 | 41 | Under 11 | $572 |
| Revlimid Lenalidomide | 29 | 29 | Under 11 | $454K |
| Ibrance Palbociclib | 28 | 30 | Under 11 | $505K |
| Imbruvica Ibrutinib | 27 | 27 | Under 11 | $433K |
Brand drugs: - claims; generic drugs: 922 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Elham Abbasi-Hafshejani $15.3 ($15.3 in general payments such as food, travel and fees) from 2 companies. The largest payer was Amneal Pharmaceuticals LLC with $15.3.
| Company | Payments | Amount |
|---|---|---|
| Amneal Pharmaceuticals LLC AMRX | 1 | $15.3 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.